Featured News

The Celiac Disease Foundation, a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease, is pleased to honor U.S. Senator Richard Blumenthal (D-CT)…

Dear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy,…

The Celiac Disease Foundation and a powerful, inspired team of advocates from across the country traveled last week to Washington, D.C., meeting with more than 30 bipartisan congressional offices to…

The ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.

For those living with celiac disease, every meal comes with a question: Is this truly safe to eat? While the gluten-free diet is the only available treatment, researchers are working…

The recent FDA clearance of the GlutenID genetic test has sparked discussion about its role in celiac disease screening. Celiac disease has a strong genetic component, and screening is generally recommended for…

CODEX issues call for Expert Advisors, New Data to Support Food Labeling Standards for Gluten For individuals with celiac disease, the definition of “gluten-free” isn’t just a label – it’s…

The Center for Celiac Research and Treatment at Mass General for Children (MGfC) has appointed Maureen Leonard, MD, MMSc as its new director. Dr. Leonard, who previously served as the…

                Celiac Disease Foundation Showcases Research and Advocacy at AOECS 2024 Reinforcing our commitment to advancing celiac disease research, education, and advocacy on…

  The Celiac Disease Foundation proudly demonstrated its global leadership in the celiac disease community and commitment to global partnerships at the first ever Latin American Society for the Study…